Trio-Tech (TRT) Competes with Teradyne (TER)

Trio-Tech International (TRT) competes directly with Teradyne (TER).

Last quarter, TRT reported stronger year-over-year revenue growth than TER, and as China's economy continues to recover, TRT's revenue growth is going to rapidly accelerate.

TER is currently trading with an enterprise value/revenue ratio of 7.705, which is well above its 10-year median multiple of 3.733.

We are not saying TRT will reach an enterprise value/revenue ratio of 7.705 like TER, but TRT will definitely see its enterprise value/revenue ratio rise to 1 or 2 in the near-term especially with its gross margins beginning to increase significantly.

Past performance is not an indicator of future returns. NIA is not an investment advisor and does not provide investment advice. Always do your own research and make your own investment decisions. This message is meant for informational and educational purposes only and does not provide investment advice.